Clinical Trial Results

Showing: All studies [change]
Condition: Lupus 25 trials found
New Search
Filter
Trial Phase
Study Type
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
PHASE1INTERVENTIONAL Bethesda, Maryland +4 more
RECRUITING
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
PHASE2INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
PHASE1, PHASE2INTERVENTIONAL Mianyang, Sichuan +1 more
RECRUITING
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
PHASE2INTERVENTIONAL Loma Linda, California +4 more
RECRUITING
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Study of Systemic Lupus Erythematosus
N/AOBSERVATIONAL Bethesda, Maryland +4 more
RECRUITING
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
N/AOBSERVATIONAL Bethesda, Maryland +4 more
RECRUITING
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
PHASE2INTERVENTIONAL Lawrenceville, Georgia +3 more
RECRUITING
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
PHASE4INTERVENTIONAL Los Alamitos, California +4 more
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
PHASE1, PHASE2INTERVENTIONAL Bethesda, Maryland +4 more
RECRUITING
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
PHASE1INTERVENTIONAL Diepenbeek, Limburg +4 more
RECRUITING
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
PHASE1, PHASE2INTERVENTIONAL Beijing, China,Beijing +4 more
RECRUITING
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
PHASE3INTERVENTIONAL Kissimmee, Florida +4 more
RECRUITING
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Systemic Lupus Erythematosus in Gullah Health
N/AOBSERVATIONAL Charleston, South Carolina +4 more
RECRUITING
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
PHASE1, PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
PHASE2INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
PHASE2INTERVENTIONAL Salvador, Estado de Bahia +4 more
RECRUITING
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
N/AOBSERVATIONAL Washington, District of Columbia +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type